In fact, as an example, the miR-122a-meadiated regulation via three miR-122a target sites downstream E1A gene and another regulation approach based on CR2-deletion targeting to Rb-deficient cancer cells has been successfully combined to fine-tune oncolytic adenoviruses [27]. The gene discussed is RB1; the disease is cancer.